Amoéba
Develops natural microbiological solutions to manage bacterial and fungal risks.
ALMIB | PA
Overview
Corporate Details
- ISIN(s):
- FR0011051598 (+2 more)
- LEI:
- 9695005QNE7C8Z0LXU64
- Country:
- France
- Address:
- 38 AVENUE DES FRERES MONTGOLFIER, 69680 CHASSIEU
- Website:
- https://amoeba-nature.com/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of other chemical products
Description
Amoéba is a biotechnology company that develops natural microbiological solutions for managing bacterial and fungal risks. The company's core technology is based on the patented use of the amoeba *Willaertia magna* C2c Maky and its biocidal properties. Its primary focus is on agricultural biocontrol, offering a biofungicide derived from a mechanically lysed amoeba. This product targets plant diseases such as mildews, rusts, and powdery mildew, providing a biological alternative to chemical treatments. Amoéba has also developed applications for its technology in the treatment of bacterial risk in industrial water systems, on surfaces, and for chronic wounds.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2023-04-19 17:45 |
AMOÉBA : ASSEMBLEE GENERALE ORDINAIRE ET EXTRAORDINAIRE DU 25 MAI 2023
|
French | DOC • 338.9 KB | ||
| 2023-04-18 17:55 |
AMOEBA : DOCUMENT D'ENREGISTREMENT UNIVERSEL 2022
|
French | DOC • 5.0 MB | ||
| 2023-04-18 17:45 |
AMOÉBA annonce la mise à disposition du Document d’Enregistrement Universel 202…
|
French | DOC • 314.8 KB | ||
| 2023-04-18 17:45 |
AMOÉBA announces the availability of the 2022 Universal Registration Document i…
|
English | DOC • 283.8 KB | ||
| 2023-04-18 08:42 |
URD 2022
|
French | DOC • 5.0 MB | ||
| 2023-03-31 08:30 |
Amoéba announces its collaboration with Nissan Chemical Corporation for the bio…
|
English | DOC • 441.7 KB | ||
| 2023-03-31 08:30 |
Amoéba annonce sa collaboration avec Nissan Chemical Corporation pour l’applica…
|
French | DOC • 388.3 KB | ||
| 2023-03-30 17:45 |
Amoéba : Résultats 2022 - Une année exceptionnelle confirmant le potentiel d’Am…
|
French | DOC • 688.2 KB | ||
| 2023-03-30 17:45 |
Amoéba : 2022 annual results – An exceptional year which confirms Amoéba’s pote…
|
English | DOC • 728.2 KB | ||
| 2023-03-29 17:45 |
Amoéba obtains €5.9 million in funding from BPI France as part of France 2030 p…
|
English | DOC • 458.7 KB | ||
| 2023-03-29 17:45 |
Amoéba obtient un financement de 5,9 M€ de BPI France dans le cadre de France 2…
|
French | DOC • 440.1 KB | ||
| 2023-03-13 17:45 |
AMOEBA announces initiation report from the analyst Edison Group
|
English | DOC • 400.5 KB | ||
| 2023-03-13 17:45 |
AMOEBA annonce la publication d’une étude d’initiation de couverture financière…
|
French | DOC • 363.0 KB | ||
| 2023-03-02 17:45 |
AMOEBA : Déclaration du nombre de droits de vote et d’actions
|
French | DOC • 223.6 KB | ||
| 2023-02-16 17:45 |
AMOEBA submits the building permit application for its 100% biocontrol manufact…
|
English | DOC • 3.2 MB |
Automate Your Workflow. Get a real-time feed of all Amoéba filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Amoéba
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Amoéba via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-08-30 | N/A | Other | Buy | 6,300 | 3,609.90 EUR |
| 2024-08-29 | N/A | Other | Sell | 5,500 | 3,564.00 EUR |
| 2024-08-28 | N/A | Other | Buy | 3,200 | 1,782.08 EUR |
| 2024-08-27 | N/A | Other | Buy | 20,049 | 11,231.45 EUR |
| 2024-08-26 | N/A | Other | Buy | 31,107 | 17,441.69 EUR |
| 2024-08-22 | N/A | Other | Buy | 2,255 | 1,298.88 EUR |
| 2024-08-20 | N/A | Other | Buy | 16,664 | 8,838.59 EUR |
| 2024-08-19 | N/A | Other | Buy | 13,390 | 6,795.43 EUR |
| 2024-08-16 | N/A | Other | Buy | 6,745 | 3,468.28 EUR |
| 2024-08-09 | N/A | Other | Buy | 40,748 | 21,559.77 EUR |
Peer Companies
